Peanut patch treatment continues to help toddlers safely build tolerance over three years

New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut allergies. A long-term study found that a peanut patch treatment—epicutaneous immunotherapy—continued to help toddlers safely build tolerance to peanuts over three years.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup